Litcius/Paper detail

Reported Pericardial Toxicities Associated with Acute Myelogenous Leukemia Treatments: A Pharmacovigilance Analysis of the FDA Adverse Reporting Database

Scott E. Janus, Andrew C. Heisler, Mustafa Al Jammal, Nicole Chahine, Tarek Chami, Jamal Hajjari, Haytham Mously, Anshul Badhwar, Shilpkumar Arora, Taha Al‐Juhaishi, Sadeer Al‐Kindi, Brian D. Hoit

2022Current Problems in Cardiology10 citationsDOI

Topics & Concepts

MedicineCladribineCytarabineDecitabineAdverse effectFludarabinePericardial effusionInternal medicineGemtuzumab ozogamicinAdverse Event Reporting SystemLeukemiaGastroenterologySurgeryOncologyCyclophosphamideChemotherapyGene expressionStem cellDNA methylationGeneticsCD34CD33BiologyChemistryBiochemistryGeneLymphoma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia Research
Reported Pericardial Toxicities Associated with Acute Myelogenous Leukemia Treatments: A Pharmacovigilance Analysis of the FDA Adverse Reporting Database | Litcius